doi: 10.3390/nu16060800 296 Dadgar-ZankbarLMokhtaryanMBafandehEJavanmardZAsadollahiPDarbandiTet al
At present, this looks like a side effect of high-dose GLP-1-class drugs in general, rather than something specific to retatrutide
Sanjeev Sockalingam, scientific director of Obesity Canada, says accessibility to these medications is a significant consideration for his patients
DISCUSSION Melanotic Neuroectodermal Tumor of Infancy (MNTI), first described in 1918 by Krompecher, reporting 215 cases since 1992, is a rare, pigmented, benign, locally aggressive, recurrent, and possibly malignant neoplasm with metastatic capacity
BRAF inhibition decreases cellular glucose uptake in melanoma in association with reduction in cell volume